AIDS across Europe, 1994–98: the EuroSIDA study

Amanda Mocroft(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Ole Kirk(University of Copenhagen), Christian Pradier(Université Côte d'Azur), Antonio Chiesi(Istituto Superiore di Sanità), Margaret Johnson(Duke University), F Mulcahy(St. James's Hospital), Christine Katlama(Université Paris Cité), AN Phillips(The Royal Free Hospital), Francisco Antunes(University of Lisbon)

The Lancet

July 1, 2000

10.1016/s0140-6736(00)02504-6

Cited by 461

Related Papers

Industrial enzyme applications

|Current Opinion in Biotechnology|2002|1.5k

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

|The Lancet|2003|1.2k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study

|AIDS|2003|987